Medpace (MEDP) Earnings Date, Estimates & Call Transcripts

$327.80

-11.58 (-3.41%)

(As of 09/10/2024 ET)

Upcoming Earnings Date: Oct. 28Estimated
Actual EPS (Jul. 22): $2.75 Beat By $0.21
Consensus EPS (Jul. 22): $2.54

MEDP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MEDP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Timothy Sykes

“Why I don’t care if the Fed cuts rates” - SYKES

In on Friday out by Monday Over the past decade I’ve made millions of dollars with a strategy I call Weekend Trading. It’s the best strategy I know of - because it revolves around making a quick trade right before the market closes on Friday afternoon… And closing the trade when the market opens the following Monday.

I’m hosting a free trading broadcast on Thursday, September 12 at 6 PM ET to show you exactly how y

Medpace Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	2	$2.08	$2.45	$2.27
Q2 2024	2	$2.01	$2.49	$2.25
Q3 2024	2	$2.28	$2.74	$2.51
Q4 2024	2	$2.56	$2.86	$2.71
FY 2024	8	$8.93	$10.54	$9.74
Q1 2025	1	$3.20	$3.20	$3.20
Q2 2025	1	$3.30	$3.30	$3.30
Q3 2025	1	$3.23	$3.23	$3.23
Q4 2025	1	$3.40	$3.40	$3.40
FY 2025	4	$13.13	$13.13		$13.13

MEDP Earnings Date and Information

Medpace last released its earnings results on July 22nd, 2024. The reported $2.75 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.54 by $0.21. The firm had revenue of $528.10 million for the quarter, compared to the consensus estimate of $528.41 million. Its revenue was up 14.6% compared to the same quarter last year. Medpace has generated $9.81 earnings per share over the last year ($9.81 diluted earnings per share) and currently has a price-to-earnings ratio of 33.4. Earnings for Medpace are expected to grow by 11.15% in the coming year, from $11.66 to $12.96 per share. Medpace has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 28th, 2024 based off prior year's report dates.

Medpace Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
10/28/2024 (Estimated)	-	-	-	-	-	-	-
7/22/2024	Q2 2024	$2.54	$2.75	+$0.21	$2.75	$528.41 million	$528.10 million
4/22/2024	Q1 2024	$2.45	$3.20	+$0.75	$3.20	$512.39 million	$511.00 million
2/12/2024	Q4 2023	$2.22	$2.46	+$0.24	$2.46	$498.72 million	$498.40 million
10/23/2023	Q3 2023	$2.05	$2.22	+$0.17	$2.22	$475.79 million	$492.50 million
7/24/2023	Q2 2023	$1.90	$1.93	+$0.03	$1.93	$433.75 million	$460.90 million
4/24/2023	Q1 2023	$1.76	$2.27	+$0.51	$2.27	$402.83 million	$434.07 million
Get the Latest News and Ratings for MEDP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medpace and its competitors with MarketBeat's FREE daily newsletter.
2/13/2023	Q4 2022	$1.78	$2.12	+$0.34	$2.12	$386.09 million	$394.10 million
10/24/2022	Q3 2022	$1.47	$2.05	+$0.58	$2.05	$357.17 million	$383.74 million
7/25/2022	Q2 2022	$1.34	$1.46	+$0.12	$1.46	$344.01 million	$351.21 million
4/25/2022	Q1 2022	$1.26	$1.69	+$0.43	$1.69	$327.09 million	$330.90 million
2/13/2022	Q4 2021	$1.25	$1.32	+$0.07	$1.32	$309.03 million	$308.55 million
10/24/2021	Q3 2021	$1.07	$1.29	+$0.22	$1.29	$291.55 million	$295.57 million
7/25/2021	Q2 2021	$0.99	$1.06	+$0.07	$1.06	$271.20 million	$278.29 million
4/25/2021	Q1 2021	$1.01	$1.14	+$0.13	$1.20	$266.48 million	$260.00 million
2/14/2021	Q4 2020	$1.24	$1.35	+$0.11	$1.43	$246.41 million	$259.68 million
10/31/2020	Q3 2020	$1.07	$1.09	+$0.02	$1.17	$223.56 million	$230.37 million
7/27/2020	Q2 2020	$0.40	$0.68	+$0.28	$0.72	$181.17 million	$205.00 million
4/28/2020	Q1 2020	$0.77	$0.76	($0.01)	$0.76	$226.23 million	$230.88 million
2/24/2020	Q4 2019	$0.75	$0.85	+$0.10	$0.92	$221.73 million	$229.89 million
10/29/2019	Q3 2019	$0.71	$0.71	-	$0.79	$217.14 million	$216.20 million

Medpace Earnings - Frequently Asked Questions

When is Medpace's earnings date?: Medpace has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, October 28th, 2024 based off last year's report dates. Learn more on MEDP's earnings history.
What guidance has Medpace issued on next quarter's earnings?: Medpace updated its FY 2024 earnings guidance on Monday, July, 22nd. The company provided EPS guidance of 11.240-11.930 for the period, compared to the consensus EPS estimate of 11.250. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.2 billion.
Did Medpace beat their earnings estimates last quarter?: In the previous quarter, Medpace (NASDAQ:MEDP) reported $2.75 earnings per share (EPS) to beat the analysts' consensus estimate of $2.54 by $0.21. Learn more on analysts' earnings estimate vs. MEDP's actual earnings.
How can I listen to Medpace's earnings conference call?: The conference call for Medpace's latest earnings report can be listened to online. Listen to Conference Call
How can I read Medpace's conference call transcript?: The conference call transcript for Medpace's latest earnings report can be read online. Read Transcript
How can I view Medpace's earnings report?: Medpace's earnings report can be found in their filing with the SEC. View SEC filing
How much revenue does Medpace generate each year?: Medpace (NASDAQ:MEDP) has a recorded annual revenue of $1.89 billion.
How much profit does Medpace generate each year?: Medpace (NASDAQ:MEDP) has a recorded net income of $282.81 million. MEDP has generated $9.81 earnings per share over the last four quarters.
What is Medpace's price-to-earnings ratio?: Medpace (NASDAQ:MEDP) has a trailing price-to-earnings ratio of 33.41 and a forward price-to-earnings ratio of 28.11. The price/earnings-to-growth ratio is 1.74.
What is Medpace's EPS forecast for next year?: Medpace's earnings are expected to grow from $11.66 per share to $12.96 per share in the next year, which is a 11.15% increase.